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Fetal growth impairment can occur in pregnancy complicated
by diabetes. Although several studies have focused the effects of
nutritional status on intrauterine development, the long-term
impact of maternal diabetes on vascular and renal function in the
offspring is poorly investigated. In the present study, blood
pressure profiles and renal function parameters were investigated
in the offspring of diabetic rats (DO). Female rats were made
diabetic throughout gestation with a single dose of streptozoto-
cyn (STZ) 10 d before mating. After weaning, the offspring had
free access to food and water. Arterial pressure was evaluated
every 15 d. Functional and morphometric kidney studies were
performed in newborn, 3, 6 and 12-mo-old male rats in DO and
in controls, C. Although maternal diabetes did not affect nephron
number in the young adult rat, glomerular hypertrophy developed
from 3 mo on. Glomerular Filtration Rate and Renal Plasma
Flow were observed to be significantly decreased in DO when
compared with C, from 3 mo on. In DO, hypertension was
observed from 8 wk on and persisted elevated throughout the
experimental period (12 mo). Vascular reactivity, evaluated in
mesenteric arterial bed showed a decreased endothelium-
dependent vasodilatation in 12-mo-old DO animals, while pre-
served response to sodium nitroprusside was demonstrated. Our
data show that exposure to intrauterine diabetes induced by STZ
does not affect nephron number in the young offspring but can
cause permanent changes in Nitric Oxide (NO)-related vascular
response, which, in turn may accelerate the natural age-related
nephron loss. (Pediatr Res 58: 1274–1279, 2005)
Abbreviations
DO, offspring from diabetic mother
NAE, net acid excretion
NB, newborn,
PAH, para-aminohippurate,
RPF, renal plasma flow
Maternal status can affect several physiologic functions of
the newborn. In addition, correlation between fetal growth
conditions and susceptibility to a number of adult chronic
diseases, including coronary heart disease, stroke and hyper-
tension have been identified (1–4). Recently, we have demon-
strated that maternal undernutrition promoted development of
adult hypertension, impairment of the renal and endothelium
functions, decreased absolute number of the nephrons and
hypertrophy of the remaining glomeruli in the adult offspring
(5–7). Although several experimental studies have focused the
effects of the maternal undernutrition on fetal “programming”
of adulthood disease, less attention has been paid to the
possible in utero late effects of maternal diabetes. In fact,
diabetes mellitus can impose several threats both to the mother
and the offspring. Experimental and clinical studies have dem-
onstrated that diabetic pregnancy increases the risk of intra-
uterine death, prematurity, perinatal mortality and congenital
malformations (8–12). Indeed, Chugh et al. (13) have demon-
strated that a sustained exposure of the fetus to elevated
concentration of glucose may result in diabetic embryopathy,
which is characterized by a multitude of congenital birth
defects, including those of the nervous, cardiovascular, skele-
tal, and renal systems. These malformations result from defects
occurring in early organogenesis including failure of neural
tube closure, caudal regression syndrome, and urogenital ab-
normalities, which can be as severe as renal agenesis (5,14–
16). Amri et al. (17) have demonstrated that exposure to
hyperglycemia in utero impairs nephrogenesis in the rat, lead-
ing to a reduced number of nephrons. This nephron deficit
could be a risk factor for the development of chronic renal
disease and hypertension in adulthood. Other studies have
shown that the offspring of diabetic mothers have higher
incidence of glucose intolerance, obesity, insulin resistance,
and hypertension in later life. Manderson et al. (18) showed
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that offspring of diabetic mothers might be at an increased risk
for the development of vascular disease in later life. Holemans
et al. (19) have suggested that maternal diabetes may also have
lasting adverse consequences on cardiovascular function of the
next generation, particularly because offspring of diabetic preg-
nant rats demonstrate overt insulin resistance in adulthood. On
the other hand, aging is associated with loss of renal mass
which, by itself, has little impact on overall renal function but
may increase the vulnerability of the kidney to other injuries
(20). The functional changes include a rise in renal vascular
resistance, a decline in GFR, and a rise in filtration fraction
(21,22). Age-related increases in renal fibrosis and in reactive
oxygen species production were also demonstrated (23,24)
The present experiments were designed to investigate the
possible effects of maternal diabetes on renal and vascular
function at different ages of the offspring. In addition, renal
morphometry and blood pressure profiles were also evaluated.
Our data show that glomerular hypertrophy and hypertension
developed in an early period of life in the offspring might be
related to vascular disfunction in this experimental model. In
the aged diabetic offspring, besides hypertension, intensifica-
tion of nephron loss was also observed.
METHODS
All procedures used in this study were approved and performed in accor-
dance with guidelines of the Ethics Committee of Biomedical Institute, Federal
University of Sa˜o Paulo and conformed to the Guide for Care and Use of
Laboratory Animals published by the US National Institutes of Health (Na-
tional Institutes of Health Publication No.85-23, revised 1996). Wistar rats
from our colony (Federal University of Sa˜o Paulo) were maintained in a room
at 22  1°C with a 12 h light cycle and 60% humidity.
Animals. Diabetes mellitus was induced by streptozotocyn (50 mg/kg),
given by a single intraperitoneal injection to female Wistar rats (250–300 g).
Control animals were given an equivalent amount of citrate buffer. Diabetic
state was confirmed 48 h after, by measuring blood glucose. Blood glucose
concentration was evaluated every three days. Only those animals with gly-
cemic levels above 250 mg/dl were considered for mating. The diabetic rats
were caged overnight with a male. Vaginal smears were taken in the following
morning and a positive smear was considered as day 0 of gestation. All dams
were housed and fed individually with the same diet. Maternal body weight
gain was measured every 3 d. After birth, each litter, consisting of 6 male rats,
was left with the mother for 28 d; when the male number was not enough to
complete 6, females were used but discarded at weaning. The offspring were
divided into two groups: a) group C—offspring of control mothers; b) group
DO—offspring of diabetic mothers. After weaning, the rats were placed in
individual cages, with free access to food and water until the time for the
experiments. Animals from both C and DO groups were used in a randomized
manner for the studies detailed below. Glycemia was measured in newborn rats
(NB), 12 h after delivery. In 3, 6 and 12 mo-old rats, glycemia was measured
in 12 h-fasted animals. Renal function was evaluated in 3, 6, and 12 mo-old
rats. In addition, kidney morphometry was performed at the same mentioned
ages and also in NB rats.
Renal function studies. The animals were anaesthetized with sodium
thiopental (30 mg/kg) and placed on a heated table to maintain body temper-
ature at 37°C. Tracheotomy was followed by insertion of polyethylene cath-
eters into the jugular vein for infusions, and into the carotid artery for blood
sampling. Urine was collected from a catheter inserted into the bladder. After
the surgical procedure, one hour stabilization period was allowed before the
beginning of three collection periods. The animals were primed with 1 mL of
saline containing inulin (300 mg/kg, and sodium para-aminohippurate (PAH, 2
mg/rat) and then submitted to continuous infusion of a saline solution con-
taining inulin (15 g/L) and PAH (4 mg/L) at 0.08 mL/min. Plasma and urine
inulin and PAH concentrations were measured by colorimetry for estimation of
GFR (GFR) and renal plasma flow (RPF). Blood and urine Na were measured
using ion selective electrode (Ciba-Corning 614 Na/K analyzer). Net acid
excretion (NAE) was calculated using the formula: NAE  TA  NH4 
HCO3, where TA is titratable acidy in urine measured by microtitration with
0.01 M sodium hydroxide, NH4, excreted amount of ammonium evaluated by
colorimetry and HCO3 is the net bicarbonate excretion calculated with a
Blood Gas Analyzer (Ciba Corning, model 248). For protein excretion deter-
mination, rats were placed in metabolic cages and a 24-h urine collection was
performed. Proteinuria was measured from 2 mo on, every 4 wk. Protein
concentration was measured by precipitation with 3% sulfosalicylic acid.
All drugs and reagents were purchased from Sigma Chemical Co.-Aldrich,
St. Louis Missouri, USA.
Morphometric study. The morphologic evaluation was obtained by the
following methodology: both kidneys from rats of each group were dissected
out rapidly, cleaned of connective tissue, weighed and fixed in Bouin. Kidneys
longitudinally cut were wax embedded and histologic sections (5 m width)
near renal hilus were performed. Sections cut were stained with hematoxilin
and eosin to morphologic analysis. Glomerular area and diameters were
measured using an image analysis program, Image-Pro PLUS, Media Cyber-
netica, MD, USA. Images were acquired in microscope (Leica DMLB, Wet-
zlar, Germany) connected to a microcomputer by a video camera (Sony-CCD-
IRIS). Ten different images (fields) in 10 different slides were analyzed for
each group. Each image had an area of 285 000 m2. The number of glomeruli
was also evaluated in these same fields. Total glomeruli number was calculated
taking into account the glomeruli number per field, the number of studied
fields, the glomerular diameter and the section thickness. Two different inves-
tigators who were unaware of the origin of the specimens performed this study.
Measurement of systolic blood pressure. Systolic blood pressure was
determined in conscious rats from both groups by an indirect tail-cuff method
(Harvard Apparatus, UK). Before the effective measurements, rats were ade-
quately trained; briefly, animals were placed in the restrainers for several
times. They were covered with a dark tissue; after this step, they remained
calm and the pressure records were made after a 15 to 20 min of quietude. The
ambient was silent, with constant temperatures and the measures were always
performed by the same person. Three consecutive measures were taken and if
a great variability was found, all the values were discarded and in the following
day, the procedures were repeated Rats were preheated at 40°C for 5 min, and
then three stable consecutive measurements of blood pressure were averaged.
Vascular reactivity in vivo in mesenteric microvessels. At 12 mo of age,
males from both C and DO groups were used in a randomized manner for the
vascular study. Rats were anesthetized with chloral hydrate (450 mg/kg, s.c),
and the mesentery was exteriorized and arranged for microscopic observation
in situ according to Zweifach (23) with slight modifications by Fortes et al.
(24). Changes in the diameter of second order arterioles were measured
following the application of vasoactive drugs: ACh (300 g/mL); BK (3.0
g/mL) and SNP (1.0 mg/mL) in a standard volume of 0.01 mL and were
removed by washing out with the warmed Ringer-Locke solution. For each
animal, at least three different microscopic fields were observed and the
arteriole diameter measured. The rats were killed by excessive anesthetic dose.
Statistical analysis. Statistical analysis was performed by unpaired t test,
Mann-Whitney U-test or by analysis of variance, followed by the Scheffe´ test,
where appropriate. Values that were not normally distributed were subjected to
the Kruskal-Wallis test, followed by Dunn’s posttest, when necessary. Statis-
tical significance was defined as p  0.05. The results are reported as means
 SEM.
RESULTS
Effect of maternal diabetes on body weight, glycemia and
blood pressure levels in the adult offspring. As shown in Table
1, in NB, no differences were observed between C and DO
concerning body weight. However, from 6 mo on, DO tended
to increase the body weight, which at 12 mo, was significantly
higher, as shown in Fig. 1. As also shown in Table 1, from NB
period until 12 mo, renal weight increased both in C and DO.
However, the increment in renal weight assumed different
profiles; in C, the maximum weight was attained at 3 mo while
after this period a slight decline was observed. In DO, kidney
weight continued to increase until 12 mo. Glycemia remained
at normal levels in all the studied groups. In DO animals, from
3 mo on, significantly higher pressures were observed when
compared with the respective control animals (Fig. 2). Hyper-
tension lasted until the end of the observation period.
Effect of maternal diabetes on renal function. Proteinuria
remained unchanged in DO when compared with age-matched
controls (data not shown). As shown in Table 2, with age, GFR
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and RPF tended to decrease in both C and DO. However, in
DO, mean values for these parameters were significantly de-
creased in all the studied periods, when compared with age
matched controls. As also shown in this table, absolute net acid
excretion (NAE) decreased in DO while fractional excretion of
Na increased in both 6 and 12-mo-old DO rats, suggesting
impairment in Na conservation. As seen in Fig. 3, when NAE
values were calculated as a function of GFR, in C, with age,
values tended to increase while in DO they were accentuately
decreased, suggesting an impairment in tubular acid excretion.
Taken together these results suggest that maternal diabetes may
accentuate the natural age-related decay, acting as a negative
adjuvant in the physiopathology of the aging process.
Effect of maternal diabetes on renal morphology. As ex-
pected, from newborn period until 3 mo after birth, increased
glomerular diameters were observed both in C and DO groups.
However, a significant increase in glomerular area was ob-
served in 3 mo-old DO rats, when compared with respective
age-matched control, which persisted until the end of the
experimental observation; these data suggest that glomerular
hypertrophy was an early event in this DO model.
As shown in Fig. 4, glomeruli number determined 3 mo after
birth was the same for C and DO but in 12 mo-old rats, DO had
about 20% fewer.
Effect of maternal diabetes on vascular function—
Responses to Acetylcholine, Bradykinin and Sodium Nitro-
prusside. There were no differences in the baseline diameter
between the control and restricted offspring (18.65  0.57
versus. 19.91  0.65 m). The magnitude of ACh (Fig. 5A)
and BK (Fig. 5B) responses was significantly less in DO
compared with control group. In contrast to the effects ob-
served with these agents, SNP produced similar vasodilatation
in the control and DO groups (Fig. 5C).
DISCUSSION
Clinical and experimental studies point to the importance of
intra-uterine environment in determining the metabolic, car-
diovascular and endocrine disorders in the offspring. Maternal
diabetes is recognized as an important cause of congenital
anomalies, progeny hyper or hypoglycemic syndromes, with
all the consequences of these metabolic disturbances (9,14,15).
In this study we have demonstrated that gestational diabetes
mellitus promotes remarkable changes in both kidney function
and vascular reactivity in the mature offspring. Our data con-
cerning DO model point to an interesting model in which,
although a normal nephron number is observed in the young
rat, two important factors, which contribute to the progression
of renal disease, systemic hypertension and glomerular hyper-
trophy are present. In our model, although decreased nephron
number was not observed in young animals, a significant
decrease in nephron number was observed in 12 mo-old DO.
These findings suggest that maternal diabetes not only repre-
sent a new component to the growing list of causes that
contribute to the fetal origins of adult-onset diseases but also
can accelerate the aging process of nephron loss. In a previous
Table 1. Effect of maternal diabetes on offspring body and kidney weight
Newborn 6 M 12 M
C (26) DO (20) C (20) DO (20) C (20) DO (20)
Body weight (g) 5.56  0.13 5.71  0.08 377.6  7.89 407.7  4.19* 410  3.67 471.4  8.3*
Kidney weight (g) 0.042 0.01 0.029  0.001* 1.21  0.03 1.41  0.04 1.42  0.03 1,42  0.03
Kidney weight/Body weight 0.55 0.01 0.503  0.01 0.31  0.005 0.34  0.008 0.34  0.007 0.32  0.008
Blood glucose (mg/dl) 111.4 8.27 91.0  7.88 102  2.59 116.3  6.43 115.1  6.61 114.2  9.57
C are control rats. DO are the offspring of diabetic dams. Data are expressed as mean  SEM. Numbers in parentheses are the number of animals in each
group. Comparisons are made between control and offspring from diabetic mothers at the same age. Significance level is p  0.05 (* C vs. DO).
Figure 1. Effect of maternal diabetes on body weight in the offspring.
Maternal diabetes promoted a significant increase in BW of aged rats. Com-
parisons were made among animals of the same age. Number of animals: C (Œ,
n  30) and DO (, n  26). Significance level: p  0.05 (* C vs DO)
Figure 2. Effect of maternal diabetes on blood pressure levels in the offspring.
Maternal diabetes promoted a significant increase in the offspring BP from 3
mo on. Comparisons were made among animals of the same age. Number of
measurements: C (■, n  20) and DO (Œ, n  18). Significance level: p 
0.05 (* C vs. DO);
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study, Amri et al. (17) suggested that hyperglycemic environ-
ment is able to impair in vitro metanephrons development. The
authors showed a decreased nephron number in the offspring of
STZ-treated dams, induced to diabetes at the beginning of
pregnancy. In our model, diabetes was induced before preg-
nancy, in a time were STZ is expected not to affect, directly,
pancreatic development. On the other hand, in Amri studies,
(17) the nephron count was performed by using glomeruli
isolation. In our study, we have used a methodology in which
glomeruli number is counted in 40 fields of both kidneys and
glomerular diameter and area are calculated by using a com-
puter program. Changes in renal function were also shown by
Nelson et al. (25) in Pima Indians children, exposed to intra-
uterine diabetes. The authors showed high levels of urinary
albumin excretion in that population, suggesting increased risk
of renal disease. Although proteinuria was not observed in DO
group, significant decrease in GFR, RPF and urinary flux
suggest that the natural age-related decline in renal function,
which was also present in C group, was accelerated in these
rats; the increase in glomerular area shown in DO characterizes
glomerular hypertrophy known to be the early event in the
progression of glomerular damage (26–28).
Both experimental and clinical studies have indicated a
decreased nephron number as a common denominator of hy-
pertensive states (29–31). In some models of reduced nephron
numbers, systemic hypertension and glomeruli hypertrophy are
interpreted as compensatory mechanism to maintain renal
function in adequate levels (32). In a model of renal ablation
performed in newborn rats, Woods et al. (31) showed that
hypertension developed from 8 wk on and proteinuria was
significantly higher in the 20-wk-old group, suggesting that
hypertension preceded glomerular damage, which was signif-
icant only in the older group. Our previous work in the aged
offspring of food restricted mothers showed that glomerular
involvement occurred independently of systemic hypertension,
which was prevented by L-arg administration (33), similar to
Table 2. Parameters of renal function in the offspring of diabetic rats
Group N GFR ml/min/kg RPF ml/min/kg FENa% U/P FF% NAE Eq/min/kg
3 M C 24 7.17  0.42 19.97 1.87 0.45  0.07 52.93 2.09 35.75  .048 6.34 0.14
D 20 4.67  0.17* 15.86 0.98 0.41  0.04 40.37 1.14 31.97  2.53 4.78 0.27
6 M C 32 4.66  0.27† 11.58 0.67† 0.45  0.03 51.75 3.36 40.86  1.51 5.25 0.36
D 28 2.83  0.22*† 12.19 1.43 1.07  0.31@ 39.32  2.28 31.72  3.21* 2.59 0.15
12 M C 16 4.70  0.33§ 14.90 0.71§ 0.42  0.07 52.91 3.38 31.58  1.38 6.48 0.47
D 13 2.08  0.15*‡§ 6.18 1.25*‡§ 1.38  0.37@# 43.97  9.10 42.05  4.11 1.06 0.17
Data expressed as mean  SEM. N are the number of experiments. Significance level is p  0.05.
Comparisons are made between control and offspring from diabetic mothers at the same age and between group at different ages.
* p  0.05 for C and DO at the same ages.
† 3 vs 6 months for the same experimental groups.
‡ 6 vs 12 months for the same experimental group.
§ 3 vs 12 months for the same experimental group.
Figure 3. Net Acid excretion expressed per milliliter of GFR. Maternal
diabetes caused a significant decrease in net acid excretion (NAE) from 6 mo
on. Data from control (C: ■, n  24) and from diabetic offspring (DO: Œ, n
 24) rats. Significance level: p  0.05 (* C vs. DO).
Figure 4. Numbers of glomeruli in the offspring from control () and
diabetic mothers (). Maternal diabetes caused a significant decrease in
glomeruli number in 12 mo-old DO rats. Number of measurements: 3 mo-old,
C (n  49) and DO (n  50). 12 mo-old C (n  50) and DO (n  50).
Significance level: p  0.05 (* C vs. DO).
Figure 5. Percentage of change in vascular diameter of mesenteric arterial
bed. Maternal diabetes caused an impaired response to endothelium-dependent
agents Bar graphs shows the response of the mesenteric microvessels to: (A)
acetylcholine (300 g/mL); (B) bradykinin (3,0 g/mL) and (C) sodium
nitroprusside (1.0 mg/mL) in control (, n  06) and DO (; n  09) groups.
Values are expressed as mean  SEM * p  0.05 compared with control
group.
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the findings from Floege et al., in Milan normotensive rats, that
showed that an early podocyte damage was observed, preced-
ing glomerulosclerosis, in the absence of systemic hyperten-
sion, hyperglycemia and glomerular hypertension (34). On the
other hand, hypertension by itself plays an important role in the
progression of renal disease (29,30). A persistent elevation in
blood pressure can be transmitted to glomeruli leading to
progressive injury, which in turn, can aggravate systemic
hypertension. In the aging spontaneously hypertensive rats
(SHR), Tolbert et al. (35), showed that at 9 mo of age,
glomerular hypertension developed because of a small increase
in systemic blood pressure and a decline in preglomerular
vascular resistance, allowing transmission of elevated systemic
pressure to the glomerular capillaries. In the present study,
hypertension was an early event in DO suggesting that it could
be the initial trigger factor of renal function impairment, which
is reflected by glomerular hypertrophy and changes in renal
function parameters. However, other hypertrophyc stimuli may
be present in this model. For example, TGF is known to be
increased in glomeruli of human and experimental diabetes
(36). The possibility of transference of mother’s phenotypic
characteristics was demonstrated by Malathi et al. (37) that
showed that offspring originated from hyperglycemic mothers
had also several metabolic disturbances similar to the hyper-
glycemic dams. In their study, they concluded that a dietary
modification in the early postnatal life of the mothers sets up a
vicious cycle of spontaneous transfer of the phenotype to its
progeny.
To investigate alterations of vascular reactivity in the adult
offspring from diabetic mothers, responses to acetylcholine,
bradykinin and sodium nitroprusside were investigated.
Whereas the responses induced by endothelium-dependent va-
sodilators were decreased in mesenteric microvessels, no dif-
ferences could be detected to sodium nitroprusside. Therefore,
we may suggest that it is not the smooth muscle vasodilating
capability that is reduced in mesenteric bed from offspring of
diabetic rats, but some function related to the endothelium.
Corroborating our in vivo data, in vitro studies have demon-
strated that severe maternal diabetes can led to vascular dys-
function in adult offspring, characterized by enhanced sensi-
tivity to noradrenaline and abnormal endothelium-dependent
relaxation to acetylcholine and bradykinin in small mesenteric
arteries (38). The origin of the vascular dysfunction induced in
these offspring cannot be directly inferred from the present
study. However, it seems that these animals had acquired an
endothelial defect similar to that observed in arteries of dia-
betic adult rats (39) and in patients with diabetes, (40–43)
suggesting that these disturbances, which were already de-
scribed in diabetes, could be transferred to the fetus, changing
blood pressure regulation and interfering in the developing
organs.
The exact mechanism by which maternal diabetes impairs
the endothelial function is not fully elucidated. Considering
that nitric oxide (NO) is the main agonist responsible for the
endothelium-dependent relaxation induced by acetylcholine or
bradykinin, maternal diabetes may cause a reduction in NO
synthesis and/or bioavailability, decreasing the endothelium-
dependent vasodilation in the adult offspring. However, studies
are necessary to evaluate the mechanisms involved in this
alteration of the vascular function induced by maternal diabe-
tes.
Although our data point to systemic hypertension as the
primary cause of both glomerular hypertrophy and renal func-
tion impairment in DO model, the role of the kidney in
perpetuating vascular alterations is a possibility that cannot be
ruled out and need to be addressed in further investigations. To
date, no study has specifically examined the late consequences
of maternal diabetes on offspring blood pressure regulation and
kidney function. Most observations have been found directly in
the presence of diabetic status or have focused the disturbances
in the hormonal control of glycemia in the offspring of diabetic
mothers. Our data suggest that maternal diabetes can represent
an important cause of hypertension and renal dysfunction latter
in life, reinforcing the concept of fetal programming of adult
diseases.
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